These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2410102)

  • 41. Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs.
    Levin VA; Landahl HD
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):387-403. PubMed ID: 3936919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system.
    Whitesell L; Geselowitz D; Chavany C; Fahmy B; Walbridge S; Alger JR; Neckers LM
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4665-9. PubMed ID: 8506315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The intracerebral penetration of intraventricularly administered methotrexate: a quantitative autoradiographic study.
    Grossman SA; Reinhard CS; Loats HL
    J Neurooncol; 1989 Nov; 7(4):319-28. PubMed ID: 2585028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of alteration of cerebrospinal fluid bulk flow on nicotine cerebrospinal fluid exit transfer kinetics.
    Karol MD; Veng-Pedersen P; Brashear RE; DeAtley RE
    J Pharm Sci; 1988 Jul; 77(7):571-8. PubMed ID: 3171944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The toxicological evaluation of tallysomycin s10b--biosynthetic tallysomycin derivative.
    Buroker RA; Comereski CR; Barnett D; Hirth RS; Madissoo H; Hottendorf GH
    Drug Chem Toxicol; 1984; 7(3):259-72. PubMed ID: 6203697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penetration of ascorbic acid from cerebrospinal fluid into brain.
    Spector R
    Exp Neurol; 1981 Jun; 72(3):645-53. PubMed ID: 6786911
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
    Fleischhack G; Jaehde U; Bode U
    Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cimetidine elimination from the cerebrospinal fluid of the rat.
    Whittico MT; Giacomini KM
    Pharm Res; 1988 Oct; 5(10):628-33. PubMed ID: 3244614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient blindness and seizure associated with cisplatin therapy.
    Cattaneo MT; Filipazzi V; Piazza E; Damiani E; Mancarella G
    J Cancer Res Clin Oncol; 1988; 114(5):528-30. PubMed ID: 3182914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
    Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
    Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution in cerebrospinal fluid, blood, and lymph of epidurally injected morphine and inulin in dogs.
    Durant PA; Yaksh TL
    Anesth Analg; 1986 Jun; 65(6):583-92. PubMed ID: 3706799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beagles.
    Levin VA; Byrd D; Sikic BI; Etiz BB; Campbell J; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3810-5. PubMed ID: 2410102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
    Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.
    Lopez JA; Beardsley GP; Krikorian JG; Mortara RW; Agarwal RP
    Cancer Res; 1983 Nov; 43(11):5190-3. PubMed ID: 6616454
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.